These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35429548)

  • 1. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.
    Charkoftaki G; Tan WY; Berrios-Carcamo P; Orlicky DJ; Golla JP; Garcia-Milian R; Aalizadeh R; Thomaidis NS; Thompson DC; Vasiliou V
    Chem Biol Interact; 2022 Jun; 360():109931. PubMed ID: 35429548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis.
    Dong Y; Qiu P; Zhao L; Zhang P; Huang X; Li C; Chai K; Shou D
    Phytomedicine; 2020 Aug; 74():152697. PubMed ID: 30392748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
    Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling.
    Xiao L; Xu G; Chen S; He Y; Peng F; Yuan C
    Phytomedicine; 2023 Nov; 120():155055. PubMed ID: 37678053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease.
    Ferrell JM; Dilts M; Pokhrel S; Stahl Z; Boehme S; Wang X; Chiang JYL
    Cell Mol Gastroenterol Hepatol; 2024; 18(1):71-87. PubMed ID: 38417701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency.
    Tran M; Yang Z; Liangpunsakul S; Wang L
    Alcohol Clin Exp Res; 2016 Dec; 40(12):2548-2556. PubMed ID: 27790731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
    Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease.
    Assiri MA; Ali HR; Marentette JO; Yun Y; Liu J; Hirschey MD; Saba LM; Harris PS; Fritz KS
    Hum Genomics; 2019 Dec; 13(1):65. PubMed ID: 31823815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury.
    Thompson KJ; Nazari SS; Jacobs WC; Grahame NJ; McKillop IH
    Alcohol Alcohol; 2017 Nov; 52(6):629-637. PubMed ID: 29036399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
    Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
    Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Gentiana dahurica Fisch on alcoholic liver disease revealed by RNA sequencing.
    Cao H; Xi S; He W; Ma X; Liu L; Xu J; Zhang K; Li Y; Jin L
    J Ethnopharmacol; 2021 Oct; 279():113422. PubMed ID: 33007391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kefir Ameliorates Alcohol-Induced Liver Injury Through Modulating Gut Microbiota and Fecal Bile Acid Profile in Mice.
    Cui Y; Jing C; Yue Y; Ning M; Chen H; Yuan Y; Yue T
    Mol Nutr Food Res; 2024 Jan; 68(1):e2300301. PubMed ID: 37933689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury.
    Kong B; Zhang M; Huang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Guo GL
    Dig Liver Dis; 2019 Apr; 51(4):570-576. PubMed ID: 30803859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
    Zhang M; Kong B; Huang M; Wan R; Armstrong LE; Schumacher JD; Rizzolo D; Chow MD; Lee YH; Guo GL
    Dig Liver Dis; 2018 Oct; 50(10):1068-1075. PubMed ID: 29730159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.
    Goudarzi M; Koga T; Khozoie C; Mak TD; Kang BH; Fornace AJ; Peters JM
    Toxicology; 2013 Sep; 311(3):87-98. PubMed ID: 23851158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.